Clinical Trials

• NCT07028853

  A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MEVROMETOSTAT (PF-06821497) WITH ENZALUTAMIDE IN METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER

  This study is currently enrolling.

  Associated Conditions: Urology of Denver

  Research Area: Colorado Cancer Research

  Research Location: Porter, Colorado